Table 2.
Comparison of baseline demographic, clinical, and outcomes for patients excluded from analysis as a result of missing admission or post-discharge hematocrit values (N = 213) and those included in all analyses (N = 493)
| Demographic or clinical characteristic | Excluded as a result of missing hematocrit measures (N = 213) | Included in all analyses (N = 493) | P value |
|---|---|---|---|
| Age (months), mean (SD) | 52.0 (30.9) | 52.8 (29.7) | 0.729 |
| Sex (male), N (%) | 115 (54.0) | 251 (50.9) | 0.503 |
| Blantyre coma score | 0.006 | ||
| 0 | 29 (13.6) | 33 (6.7) | |
| 1 | 90 (42.3) | 201 (40.8) | |
| 2 | 94 (44.1) | 259 (52.3) | |
| qHRP2, mean (SD) | 6,973.3 (10,117.5) | 6,386.0 (10,666.8) | 0.504 |
| Parasite count, mean (SD) | 197,441.9 (390,269.2) | 148,844.2 (362,765.1) | 0.100 |
| Splenomegaly, N (%) | 62 (29.1) | 127 (25.9) | 0.424 |
| Outcome, N (%) | < 0.001 | ||
| Died | 101 (48.6) | 0 (0) | |
| Survived with sequelae | 9 (4.3) | 55 (11.2) | |
| Survived without sequelae | 98 (47.1) | 437 (88.8) |
qHRP2 = quantitative histidine-rich protein 2.